In an effort to develop novel approaches to AD treatment, attention has recently been focused on several tyrosine kinases, including the members of the Abelson (Abl) tyrosine kinase and discoidin domain receptor (DDR) families that are upregulated in AD patients [9,10]. Here, DDR1 is linked to Alzheimer disease.